Comparison of the changes in the a/A oxygen ratio after administration of two surfactants for the treatment of neonatal respiratory distress syndrome

Journal of Tropical Pediatrics

Volumn 43, Issue 1, 1997, Pages 38-41

  Bassiouny, Mohamed Reda ^a,b   Remo, Carmen ^a   Cherian, Elizabeth ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; OXYGEN;

ARTERIAL OXYGEN TENSION; ARTICLE; ASSISTED VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRATRACHEAL DRUG ADMINISTRATION; LUNG ALVEOLUS OXYGEN TENSION; NEWBORN; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME;

EID: 0031042824     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/43.1.38     Document Type: Article

References (15)

1. Soll RF, McQueen MC. Respiratory distress syndrome. In: Sinclair JC, Brachen MB (eds) Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992
2. Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980; i: 55-9.
3. Shapiro DL, Notter RH, Morin FC III, et al. Double-blind randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome Pediatrics 1985, 76: 593-9.
4. Exosurf Neonatal (Colfosceril palmitate, cetyl alcohol, tyloxapol) for intratracheal suspension package insert. Research Triangle Park North Carolina: Burroughs Wellcome, August 1990.
5. Survanta (Beractant) intratracheal suspension package insert. Colomus, Ohio: Ross Laboratories, June 1991.
6. Horbar JD, Wright LL, Soll RF, et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr 1993; 123: 757-766.
7. A multicenter randomized trial comparing synthetic surfactants to modified Bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. The Vermont-Oxford Neonatal Network.
8. Ikegami M, Jobe A, Jacobs H, Jones SJ. Sequential treatments of premature lambs with an artificial surfactant and natural surfactant. J Clin Invest 1981; 68: 491-6.
9. Cummings JJ, Holm BA, Hudak ML, Hudak, Ferguson WH, Egan EA. A controlled clinical composition of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis 1992, 145: 999-1004.
10. Jobe AH, Pulmonary surfactant therapy: N Engl J Med 1993; 328: 861-88.
11. Millner A. The effect of surfactant on lung compliance, lung volume and pulmonary blood. In: Clinical Insight in RDS, New Perspectives '94 Second International Pediatric Roundtable on Respiratory Distress Syndrome, 1994; 41-7.
12. Halliday H, McCord FB, McClure G, Reid M McC. Acute effects of instillation of surfactant in severe respiratory distress syndrome. Arch Dis Childh 1989; 64: 13-16.
13. Cowan F, Whitelaw A, Wertheim D, Silverman M. Cerebral blood flow velocity changes after rapid administration of surfactant. Arch Dis Childh 1991; 66: 1105-9.
14. Heldt GP, Pesonen E, Merritt TA, Elias W, Sahn DJ. Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy. Pediat Res 1989; 25: 305-10.
15. Niijima S, Shortland DB, Levene MI, Evans DH. Transient hyperoxia and cerebral blood flow velocity in infants born prematurely and at full term. Arch Dis Childh 1988; 63: 1126-30.